NCT07124572 Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
| NCT ID | NCT07124572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Thyroid Associated Ophthalmopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2030-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-10-01 with a primary completion date of 2030-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.
Eligibility Criteria
Inclusion Criteria: * normal participants without eyelid disorders (control group) * patients with thyroid-associated ophthalmopathy (TAO group) * cooperative participants Exclusion Criteria: * participants with pupil or cornea disorders * participants with history of eye injury
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07124572 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 90 Years, studying Thyroid Associated Ophthalmopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07124572 currently recruiting?
Yes, NCT07124572 is actively recruiting participants. Contact the research team at yejuan@zju.edu.cn for enrollment information.
Where is the NCT07124572 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT07124572 clinical trial?
NCT07124572 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 500 participants.